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Abstract. 
This study primarily aimed to identify the causative species of cutaneous leishmaniasis (CL) in the Khyber 
Pakhtunkhwa Province of Pakistan and to distinguish any species-specific variation in clinical manifestation of CL. 
Diagnostic performance of different techniques for identifying CL was assessed. Isolates of Leishmania spp. were 
detected by in vitro culture, polymerase chain reaction (PCR) on DNA extracted from dried filter papers and 
microscopic examination of direct lesion smears from patients visiting three major primary care hospitals in 
Peshawar. A total of 125 CL patients were evaluated. Many acquired the disease from Peshawar and the neighboring 
tribal area of Khyber Agency. Military personnel acquired CL while deployed in north and south Waziristan. 
Leishmania tropica was identified as the predominant infecting organism in this study (89.2%) followed by 
Leishmania major (6.8%) and, unexpectedly, Leishmania infantum (4.1%). These were the first reported cases of CL 
caused by L. infantum in Pakistan. PCR diagnosis targeting kinetoplast DNA was the most sensitive diagnostic 
method, identifying 86.5% of all samples found positive by any other method. Other methods were as follows: 
ribosomal DNA PCR (78.4%), internal transcribed spacer 2 region PCR (70.3%), culture (67.1%), and microscopy 
(60.5%). Clinical examination reported 14 atypical forms of CL. Atypical lesions were not significantly associated 
with the infecting Leishmania species, nor with “dry” or “wet” appearance of lesions. Findings from this study 
provide a platform for species typing of CL patients in Pakistan, utilizing a combination of in vitro culture and 
molecular diagnostics. Moreover, the clinical diversity described herein can benefit clinicians in devising differential 
diagnosis of the disease. 
INTRODUCTION 
Leishmaniasis, caused by protozoan trypanosomatid parasites of genus Leishmania, is 
essentially a neglected tropical disease. The parasites multiply within host macrophages, 
afflicting skin (cutaneous), mucous membranes (mucocutaneous), or internal organs (visceral).
1,2
 
About 350 million people live at risk of leishmaniasis in 98 countries across five continents.
3,4
 
Based on estimates by Alvar and others (2012),
5
 the annual global incidence of visceral 
leishmaniasis (VL) is 0.2–0.4 million cases compared with 0.7–1.2 million cases for cutaneous 
leishmaniasis (CL) and mucocutaneous leishmaniasis combined (MCL). 
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A region extending from central Asia to Middle East contributes 226,200–416,400 of the 
global CL cases annually. In Pakistan, around 21,000–35,000 cases of both anthroponotic (ACL) 
and zoonotic (ZCL) forms of CL are reported.
5
 ACL is apparently sporadic and Leishmania 
tropica has been implicated as its causative agent in the country.
6–8
 It is commonly reported from 
urban centers of Punjab, Baluchistan, Azad Jammu Kashmir (AJK), Khyber Pakhtunkhwa (KP) 
and the surrounding tribal belt, known as the Federally Administrated Tribal Areas (FATA).
5,9
 In 
KP, the northwest province of Pakistan, leishmaniasis is characterized by intermittent epidemics 
attributed to L. tropica.
6,8,10
 The ZCL form, attributed to infection by Leishmania major, is more 
common further south, being described from rural and semi-urban areas of Punjab, Baluchistan, 
and Sindh provinces, where its transmission is possibly maintained through reservoir populations 
in wild mammals, particularly gerbils such as Rhombomys opimus.
11,12
 
There have been several reports from studies in Pakistan of atypical manifestations of the 
disease either due to unusual sites of lesions or their unusual morphology. Lesions on atypical 
sites lead to difficulty in differential diagnosis, for example, lips or genitalia (chancriform), toes 
and fingers (paronychial), pulp of finger (whitlow), eyelid, scalp, palm/sole (palmoplantar), and 
others.
13–16
 Similarly, many unusual clinical configurations of lesions are described including 
lupoid, keloidal, psoriasiform, erysipeloid, verrucous, zosteriform, tumorous, eczematoid, and 
acneform and so on.
16–19
 These studies of atypical manifestation in Pakistan have failed to 
provide molecular confirmation of the infecting Leishmania species. 
This study aimed to assess the demographic and clinical aspects of CL in KP Province of 
Pakistan. We also set out to identify the causative species of CL in the province and attempted to 
distinguish any species-specific clinical variants within KP. Different diagnostic approaches 
comprising microscopy (including histopathology), parasite culture, and polymerase chain 
reaction (PCR) were compared to evaluate their sensitivity and specificity. In addition, the 
diagnostic accuracy of presumptive clinical diagnosis, as performed in the participating 
hospitals, was examined using the above-mentioned diagnostic means. 
MATERIALS AND METHODS 
Study design and subjects. 
The study was conducted in the dermatology outpatient units at Kuwait Teaching Hospital 
(KWH), Khyber Teaching Hospital (KTH), and Combined Military Hospital (CMH) in 
Peshawar, KP. CMH commonly catered for army personnel who acquired CL while deployed in 
the tribal areas of FATA. The other two civilian hospitals treated patients from local and other 
adjoining regions in the outskirts of Peshawar. Clinical data and biological samples were 
collected from 125 CL patients (suspected and confirmed) visiting these major health-care 
facilities of Peshawar from May 2010 to September 2010. 
CL patients were recruited for the study based on standard diagnostic procedures practiced at 
these hospitals. KWH performed clinical diagnosis only. CMH also practiced clinical diagnosis, 
often followed by confirmatory microscopy (histopathology or exudate smears). At KTH, 
clinical diagnosis was considered inadequate and a positive microscopy of lesion smears was 
required before administering treatment. However, for this study, all suspected (microscopy 
negative) and confirmed CL patients (microscopy positive) from KTH were included. All 
participants gave written informed consent to participate in the study. Ethics Committees at 
University of Peshawar (ref. no. 28/Pharm, May 2010) and LSHTM (ref. no. 5677, March 2010) 
approved the study documentation. 
Sample collection and DNA extraction. 
Selected patient lesions (the most recent, in case of multiple lesions) were first photographed 
and standard clinical descriptions for these lesions were obtained from dermatologists. Lesions 
were punctured with sterile lancets and collected exudates were dispensed in to a biphasic culture 
medium containing rabbit blood agar and M199 medium (Sigma) supplemented with 10% heat-
inactivated fetal calf serum. Positive cultures with Leishmania viable promastigotes observed 
were expanded and cryopreserved before transfer to LSHTM for genetic analysis. Aliquots of 
each culture were thawed, spun at 2,000 rpm at 4°C for 10 minutes, the pellet washed with 
phosphate-buffered saline, and DNA extracted using the DNeasy Blood and Tissue Kit 
(QIAGEN, UK). 
At the same time, coarse porosity filter paper discs (Fisher Scientific) were used to obtain 
lesion and biopsy impressions from each patient. Filter papers were wrapped individually in 
airtight resealable bags with silica gel and stored at 4

C until further processing: 2–3 sections of 
the filter papers were punched using a Harris Uni‐Core hole punch (at least 2 mm diameter) and 
DNA extracted using a resin-based Chelex
®
 method.
20
 
Diagnostic PCR. 
Three PCR methods, targeting minicircle kinetoplast DNA (kDNA),
6
 ribosomal DNA 
(rDNA),
21
 or internal transcribed spacer 2 region (ITS2)
22
 were used for Leishmania species 
identification and discrimination in cultures and on filter paper samples. rDNA provided 
Leishmania genus-level identification, whereas kDNA and ITS2 PCRs aided in species-level 
diagnosis of the samples (Table 1). Leishmania species discrimination from cultured parasites 
was performed using only kDNA PCR, whereas samples on filter papers were subjected to all 
three diagnostic PCRs. 
Data analysis. 
For analysis, KTH and KWH were treated as a single group of civilian hospitals (KTH + 
KWH, N = 54) distinct from CMH, a military hospital (N = 71). Calculation of proportions, 
Pearson 2 test, and comparison of means by the Wilcoxon–Mann–Whitney test were carried out 
in STATA v.12. 
Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and 
McNemar’s marginal homogeneity were calculated for each diagnostic method.23 Since there is 
no known gold standard outlined for diagnosis of CL, a “consensus standard” was defined for 
this study. All samples were considered confirmed positives if they were positive 
parasitologically (by culture or microscopy) or by at least two PCR methods. Samples were 
considered confirmed negatives if they were negative by all PCR and parasitological methods or 
when only one PCR method was positive.
24–26
 
RESULTS 
A total of 125 patients with skin lesions were diagnosed as cases of CL, and treated 
according to local guidelines and protocols operating in the three participating hospitals. Our 
study did not contribute to decisions regarding management of these patients. 
Site of disease acquisition was concluded from patient travel history, taking in to account the 
incubation period and patient information. Overall, 56.1% of patients acquired the disease when 
traveling/working away from home, both in and outside KP, whereas the rest acquired the 
disease indigenously. The civilian hospitals (KWH and KTH) mainly received patients from 
Peshawar and adjoining tribal regions of Khyber Agency (mostly Jamrud, Bara, and Landi 
Kotal). Military personnel serving in north and south Waziristan (especially Miramshah and 
Wana) were observed at CMH (Figure 1). 
Comparative performance of diagnostic methods. 
Samples in cultures and on filter papers were successfully acquired from 119 and 111 of 125 
patients, respectively. Although 51 of the total 119 lesions were culture positive, only 34 of these 
could be established and propagated so that they could be further subjected to species-specific 
PCRs. Microscopy data were provided for 45 of the 71 patients at CMH and all the 16 patients 
examined at KTH (Table 2). Microscopy was not performed at KWH. 
The highest estimated prevalence of Leishmnania spp. infection, derived from PCR 
amplification of clinical samples on filter papers, was 71.2% by rDNA PCR, followed by 62.2% 
(kDNA), and 46.8% (ITS2). Culture and microscopy methods provided lower estimates of 
prevalence among the patients tested (42.9% and 42.6%, respectively) (Table 2). 
Sensitivity and specificity of each diagnostic PCR assay on filter paper samples was assessed 
against the consensus standard. kDNA PCR showed the highest sensitivity (86.5%) and 
specificity (86.5%). This PCR method was also least prone to producing false negatives (NPV = 
76.2%). rDNA PCR was the second most sensitive method (78.4%), although suffered from poor 
specificity (43.2%). ITS2 PCR was the least sensitive (70.3%) but outperformed other methods 
in specificity (100%). Parasite culture and microscopy provided sensitivity estimates of 67.1% 
and 60.5%, respectively. Only kDNA and rDNA PCR provided significant statistical equivalence 
with the consensus standard (McNemar’s test; P > 0.05) (Table 2). 
Clinical examination was a standard means of CL diagnosis at CMH and KWH. About 
80.7% (N = 88) of the clinically diagnosed CL patients (N = 109) were confirmed as parasite 
positive by at least one other diagnostic method (microscopy, culture, or PCR). On the other 
hand in KTH, eight of the 16 patients not recommended for treatment (due to negative 
microscopy) were positive by culture or PCR methods used for the purpose of this study. 
Leishmania species in KP, Pakistan. 
Of the total of 125 examined patients, 104 were validated Leishmania cases by one or more 
of the diagnostic methods used in this study. Thirty were identified to genus level (positive only 
by microscopy, culture, or rDNA PCR). 
Of the 74 samples identified to species level, 66 were L. tropica (89.2%), five were L. major 
(6.8%), and three were Leishmania infantum. Three of the L. major patients had recently traveled 
to Baluchistan, whereas the other two had travel histories to Punjab and Sindh. To date L. 
infantum has not previously been reported to cause CL in Pakistan. Two of these cases were 
army officers who contracted the disease in north Waziristan. The third case was a female of 60 
years diagnosed at AJK with no long-term travel history except to seek medical attention (Table 
3). 
Disease description and clinical diversity. 
Clinical profiles for all the patients in the study (N = 125) were assessed for different 
parameters as seen in Tables 3 and 4. Additional clinical characteristics studied were based on 
lesion descriptions as provided by the clinician. A total of 99 lesions were represented by 
photographs of sufficient quality to be adequately described. Briefly, the description included 
whether the lesion was dry, wet, or mixed types; if ulcerated whether typical or atypical 
leishmaniasis lesion; if atypical, its description based on its similarity to a certain dermatological 
condition (Figure 2). 
Duration of disease and size of lesion at presentation did not significantly vary between the 
two hospital types (MWW test, P > 0.05). Presence of singular lesions was significantly higher 
in the civilian hospitals (Pearson 2, P = 0.004). Upper extremities were the most common lesion 
site (41.6%). Most of the presented lesions were dry type (48.5%) followed by mixed (37.4%) 
and wet type (14.1%) (Table 4). The findings suggested that infecting species did not affect the 
number of lesions per patient, nor the dry/wet/mixed presentation (Table 3). 
About 26.2% of ulcerated lesions (N = 84) presented typical morphology for CL (central 
crust with raised indurated edges) as described previously.
35
 Among the rest, fourteen atypical 
forms were described (Figure 2). All the lesions with Cellulitis-like atypical morphology were 
caused by L. tropica (N = 6). No conclusions could be drawn for species specificity for other 
atypical types, as they were present in more than one Leishmania species, one or more of their 
samples were PCR negative, or were identified to genus level only (Supplemental Table 1). 
DISCUSSION 
Old World CL is a largely neglected disease. In most studies, the causative agent is either not 
reported or a particular species is assumed by convention to be present based on previously 
reported investigations. In this study, a combination of clinical, in vitro, and molecular 
diagnostic methods show that although three different species of Leishmania were found in the 
study area, the diversity of clinical presentations encountered could not be explained by species 
differences. 
Demographic characteristics of CL patients. 
Overall, the patients seen were predominantly male, and many of them were diagnosed and 
treated at a military hospital. Civilian hospital patients were also more likely to be males, 
occurring with twice the frequency of females. Similar sex-wise differences have been 
previously reported from other primary care hospitals of Peshawar
15,27
 and from active studies in 
neighboring Kabul, Afghanistan.
28
 These observations may indicate that men are at higher odds 
of acquiring CL, resulting from their occupational exposure and activities such as traveling or the 
practice of sleeping outside.
29,30
 In addition, there may also exist differences in attitudes toward 
seeking and providing treatment.
31
 
Both local hospitals observed high proportions of CL in people from western tribal regions of 
the province, particularly the Khyber Agency, and also among local Peshawaris. Khyber Agency 
borders Afghanistan with frequent movement of people to and from Kabul City. These 
individuals, probably exposed to higher transmission intensity across the border, provide 
reservoirs for the consequent anthroponotic transmission of the disease when they return to their 
home regions in Pakistan. The mean age of leishmaniasis patients in both the civilian and 
military centers (CMH = 28.5, KTH + KWH = 20.8) was in general agreement with other CL 
studies in the region.
15,27
 However, the civilian centers observed a majority of patients under 24 
years of age, suggesting long-term development of immunity in a region (Khyber Agency) with 
established endemicity for the disease,
32
 or perhaps different treatment-seeking behavior in older 
age groups. 
Proficiency of different diagnostic methods in KP. 
Comparing the diagnostic performance of different methods in this study showed that both 
the sensitivity of microscopy and the isolation rate of culture were satisfactory at 66% and 67%, 
respectively (Table 2). Previous studies in KP observed lower sensitivity of these techniques 
(36–43%) compared with parasite culture.8 However, countries from Latin America and central 
Asia witnessed a better performance of microscopy against PCR (78–90%).33–35 A major issue 
with culture-based diagnosis for CL is the high risk of contamination,
36
 as was observed in this 
study (9.2% of cultured isolates). Several factors may account for such variations in sensitivities 
including low parasite burden (e.g., chronic CL) and variation in number and distribution of the 
parasites in samples.
37,38
 
Filter papers have been used as source of clinical material in Afro-Eurasian CL, American 
CL, MCL, and extensively in VL studies.
24,39–41
 Using filter paper as clinical samples, kDNA-
targeted PCR was the most sensitive of all the methods used, as corroborated by others.
24
 kDNA 
assays are demonstrated to be more sensitive than PCR of rDNA targets due to higher copy 
number (10, 000 minicircles per parasite as compared with 40–200 copies of the rDNA 
genes).
6,24,42
 Poor performance of ITS2 observed herein might be attributed to PCR inhibition 
since nested amplification from rDNA PCR was used. Studies have, however, demonstrated low 
sensitivity of ITS2 PCR on clinical samples (21.2%).
43,44
 Sequence variation at primer sites may 
play a role here. Lack of PCR positivity in some parasitologically positive specimens might have 
been due to heterogeneous distribution of the parasite across the filter paper. This condition 
would be exacerbated in cases of low parasitemia. 
Presumptive clinical diagnosis, as performed in the participating hospitals, was shown to be 
effective in this endemic setting.
8
 Thus, although several atypical forms of the disease were 
prevalent, experienced local clinicians provided diagnoses of high accuracy, a reassuring finding 
since microscopy has the limitations of decreased sensitivity and dependence on trained technical 
staff.
3
 
Our combined diagnostic approach identified three parasite species as causative agents of 
leishmaniasis in our study hospitals: L. tropica (89.2%), L. major (6.8%), and L. infantum 
(4.1%). Leishmania tropica has been previously identified as the causative agent of ACL in KP, 
neighboring AJK, Quetta, Baluchistan, and south Punjab.
7,8,45,46
 All L. tropica samples were 
isolated from patients from KP province, substantiating the endemicity of the species in this 
region.
6–8
 All five L. major cases in this study were probably imported into the region, since the 
patients had travel histories to regions from Baluchistan, Punjab, and Sindh. All these provinces 
have endemic gerbil populations, and are suspected or known to have L. major transmission.
46–48
 
However, this does not overlook possible ZCL transmission of L. major in KP, since its 
incriminated vector Phlebotomus papatasi exists here although not as widespread as in 
Baluchistan.
49
 This study reported the first cutaneous cases of L. infantum in Pakistan. Although 
one patient contracted the disease in AJK, which is a focus of VL by L. infantum,
50–52
 the other 
two cases reported here were from KP. There are no reports of L. infantum causing CL 
circulating in KP. As the patients in this study were not examined for symptoms of VL, we 
cannot rule the possibility that VL does occur in our study area. 
Clinical features of CL in KP. 
The presence of singular lesions was significantly associated with the region of disease origin 
and type of hospital. Housing conditions and vocational behavior of the patients may account for 
the variation in number of lesions, since the military personnel visiting CMH live in tents and 
barracks and had duty hours making them more susceptible to multiple bites. A probable 
explanation can also lie in host immunity toward the disease as it has been observed that 
nonindigenous people are prone to having acute, severe, and more lesions than seen in 
indigenous cases.
53
 Mean lesion duration and lesion size at presentation were 3.5 months and 
2.02 cm, respectively. The reported values were comparable to those presented by others (6–10 
months; 1.2–1.7 cm).35,54,55 Overall, the most commonly afflicted sites effected by CL were 
exposed upper extremities and face of patients since they are the more consistently exposed 
parts.
9,28,35,55
 
The majority of L. tropica lesions observed here were dry or mixed type lesions. Leishmania 
tropica has been previously associated with production of dry type lesions, whereas wet/moist 
lesions are reported to be initiated by L. major infections.
56,57
 Studies in L. tropica–endemic 
regions of the country extensively report dry type lesions (in KP 57.6% by Bari and others
54
; in 
Multan, Punjab, 100% by Mujtaba and Khalid
58
; Larkana, Sindh, 97.6% by Bhutto and others
12
). 
Clinically dry and wet types of lesions were observed in all the three species detected in this 
study and we thus found no evidence of species-specific clinical manifestations. Similar 
conclusions were also drawn by Myint and others
46
 in Baluchistan. We also failed to find any 
evidence that atypical lesion morphology could be associated with a specific Leishmania 
species.
16,17,19
 
It is important to consider that the clinical outcome of CL does not only depend on the 
Leishmania species responsible. Rare clinical manifestations may be affected by host immune 
response, nutritional status of the host, hormonal factors, or differences in size and site of 
inoculation. Unusual morphology related to atypical site might also be because of variation in the 
skin barrier (e.g., fragility of facial skin) or the topography of the site of the sand fly bite (e.g., 
Fissure leishmaniasis when the lesion is in the center point of the lip, on the face
59
). 
CONCLUSION 
Our study provides a platform for future species typing of CL patients in KP and other 
provinces, utilizing a combination of in vitro culture and molecular diagnostics. Identifying 
potential hosts and vectors for L. infantum in the region now must be addressed. 
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FIGURE 1. Geographical distribution of cutaneous leishmaniasis (CL) cases reported in the study. Map shows 
adjoining regions of Khyber Pakhtunkhwa Province. Areas shaded gray are agencies within the Federally 
Administrated Tribal Areas (FATA). Dot on the map represents the isolation site of one or more strains. Size of the 
dot is proportional to number of strains represented by it. This figure appears in color at www.ajtmh.org. 
 
 
 
 
 
 
 
FIGURE 2. Atypical forms of cutaneous leishmaniasis (CL) lesions reported. (A) Psoraisiform, (i and ii) dry type, (iii) 
mixed type; (B) ecthymatous, mixed-type; (C) (i and ii) cellulitis like, mixed type (c) i Ecthymatous, mixed-type 
(Leishmania spp.). (D) (i and ii) Verruciform, dry type; (E) mycetomatous, mixed type; (F) lupoid, (i) mixed type 
and (ii) dry type; (G) keloidal, dry type; (H) squamous cell carcinoma like, wet type; (I) discoid lupus 
erythematosus like, dry type; (J) paronychial, dry type; (K) chanciform, wet type; (L) basal cell carcinoma like, 
mixed type; (M) erysipeloid, dry type; (N) typical (i and ii) wet type; and (O) typical (i and ii) mixed-type. LT = 
Leishmania tropica; LM = Leishmania major; LF = Leishmania infantum; L = Leishmania spp.; NA = no spp. 
identified. This figure appears in color at www.ajtmh.org. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 1 
Primers and reaction conditions used in diagnostic PCRs 
PCR Forward (F) primer/reverse (R) primer (5–3) PCR mixture Cycling conditions 
rDNA21 
Nest1 F: GCTGTAGGTGAACCTGCAGCAGCTGGATCATT 50 L reaction; 5 L 
DNA from filter papers 
(or 5 L N1), 25 L 
QIAGEN HotStar Taq 
Master Mix (QIAGEN), 
0.3 M primers 
95°C, 15 minutes 
Nest1 R: GCGGGTAGTCCTGCCAAACACTCAGGTCTG 35–40 cycles 
Nest2 F: GCAGCTGGATCATTTTCC 94°C, 0.5 minutes 
Nest2 R: AACACTCAGGTCTGTAAAC 58°C, 0.5 minutes 
 72°C, 1.5 minutes 
 60°C, 1 minutes 
 75°C, 10 minutes 
ITS222 
F: GGGAGAAGCTCTATTGTG 25 L reaction; 1 L N2 
product from rDNA 
PCR, KCL buffer (15 
mM MgCl2), 2 mM 
dNTPs, 0.4 M primers, 
1U Taq polymerase 
94°C, 2 minutes 
R: ACACTCAGGTCTGTAAAC 40 cycles 
 94°C, 20 seconds 
 53°C, 30 seconds 
 72°C, 1 minutes 
 72°C, 10 minutes 
kDNA6 
Nest1 F: C/GA/GTA/GCAGAAAC/TCCCGTTCA 50 L reaction; 5 L 
DNA from filter papers 
(OR 5 L N1), 25 L 
QIAGEN HotStar Taq 
Master Mix, 0.3 M 
primers 
95°C, 15 minutes 
Nest1 R: ATTTTTCG/CGA/TTTT/CGCAGAACG 30 cycles at 
Nest2 F: ACTGGGGGTTGGTGTAAAATAG 94°C, 1 minutes 
Nest2 R: TCGCAGAACGCCCCT 55°C, 1 minutes 
 72°C, 1.5 minutes 
 60°C, 1 minutes 
 75°C,10 minutes 
kinetoplast DNA = kDNA; PCR = polymerase chain reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 2 
Comparative performance of diagnostic methods used to identify Leishmania infections among 125 patients 
Diagnostic method No. of positives (% positivity) Sensitivity (%) (95% CI) Specificity (%) (95% CI) PPV (%) NPV (%) P value* 
kDNA PCR(N = 111) 69 (62.2) 86.5 (76.5–93.3) 86.5 (71.2–95.5) 92.8 76.2 0.197 
ITS2 PCR(N = 111) 52 (46.8) 70.3 (58.5–80.3) 100 100 62.7 < 0.01 
rDNA PCR(N = 111) 79 (71.2) 78.4 (67.3–87.1) 43.2 (27.1–60.5) 73.4 50 0.411 
Microscopy (N = 61)† 26 (42.6) 60.5 (44.4–75) 100 100 51.4 < 0.01 
Culture (N = 119)†‡ 51 (42.9) 67.1 (55.4–77.5) 100 100 63.2 < 0.01 
CI = confidence interval; ITS2 = internal transcribed spacer 2 region; kinetoplast DNA = kDNA; NPV= negative 
predictive value; PCR = polymerase chain reaction; PPV = positive predictive value; rDNA = ribosomal DNA. 
* For McNemar’s test of marginal homogeneity. 
† Both the methods contributed to formulating the “consensus” standard as no gold standard method exists. 
‡ For culture, sensitivity figure is equivalent to isolation rate. 
 
 
 
 
 
 
 
TABLE 3 
Types and number of lesions in relation to Leishmania species identified in the region 
Dry/wet* (%) Leishmania tropica (N = 59) Leishmania major (N = 4) Leishmania infantum (N = 3) P value† 
Dry 24 (40.7) 2 (50.0) 1 (33.3) 
0.171 Mixed 28 (47.5) 0 1 (33.3) 
Wet 7 (11.9) 2(50.0) 1 (33.3) 
No. of lesions (%) L. tropica (N = 66) L. major (N = 5) L. infantum (N = 3)  
Single 38 (57.6) 2 (40.0) 3 (100) 
0.241 
Multiple 28 (42.4) 3 (60.0) 0 
* Includes only those samples for which clinical description was available. 
† Calculated for Pearson 2 test. 
 
 
 
 
 
TABLE 4 
Patient information and clinical data from lesions 
 
Study center 
P value* 
All (N = 125) CMH (N = 71) KTH + KWH (N = 16 + 38 = 56) 
Median age of patients (interquartile range) 24 (17–32) 26 (22–32) 16 (7–30) – 
Sex of patients 
 Male (%) 84.8 97.2 68.5 – 
 Female (%) 15.2 2.8 31.5 – 
No. of lesions per patient 
 Mean 2.2 (95% CI 1.4–2.9) 2.6 (95% CI 1.2–3.9) 1.6 (95% CI 1.3–2.0) – 
 Range 1–47 1–7 1–47 – 
 Singular lesion (%) 59.7 48.6 74.1 
0.004 
 Multiple lesion (%) 40.3 51.4 25.9 
Duration of disease at presentation (months)† 
 Mean 3.5 (95% CI 3.1–4.0) 3.4 (95% CI 3.0–3.9) 3.7 (95% CI 2.8–4.6) 0.362 
 Range 0.36–12 0.75–10 0.36–12  
Size of lesion at presentation (cm)‡ 
 Mean (N = 108) 2.0 (95% CI 1.8–2.2) 2.1 (95% CI 1.8–2.4) 2.0 (95% CI 1.7–2.3) 0.392 
 Range 0.5–6 0.5–6 0.5–6  
Site (%)§ 
 Upper extremity 41.6 47.9 33.3 0.102 
 Lower extremity 24.8 21.1 29.6 0.276 
 Lesions on both extremities 10.4 15.5 3.7 0.032 
 Lesions on and above neck 29.6 23.9 37.4 0.112 
CI = confidence interval; CMH = Combined Military Hospital; KTH = Kuwait Teaching Hospital; KWH = Khyber 
Teaching Hospital. 
* Calculated for Pearson 2 test except for lesion duration and lesion size where the P values are for Wilcoxon–
Mann–Whitney test. 
† Earliest appearing lesion was considered in case of multiple lesions. 
‡ Size of lesion that was selected for sampling. The analysis excludes lesions that could not be measured due to 
absence of clearly defined lesion boundaries (N = 17). 
§ Percentages will not add up to 100% because of patients with multiple lesions at multiple sites (e.g., on upper 
extremities and face). 
 
 
 
 
 
 
 
 
SUPPLEMENTAL TABLE 1 
Leishmania species identified among ulcerated lesions (with typical and atypical presentations) 
 Leishmania tropica Leishmania major Leishmania infantum Leishmania genus Negative 
Typical ulcerated lesion (N = 22) 12 2 2 5 1 
Psoriasiform (N = 37) 19 1 0 11 6 
Cellulitis like (N = 6) 6 0 0 0 0 
Verruciform (wart-like) (N = 5) 3 0 0 2 0 
Echthymatous (N = 3) 1 0 0 1 1 
Lupoid (N = 2) 1 0 1 0 0 
Tumorous (squamous-cell carcinoma like) (N = 2) 0 0 0 1 1 
Keloidal (N = 1) 1 0 0 0 0 
Discoid lupus erythematosus like (N = 1) 1 0 0 0 0 
Paronychial (N = 1) 0 0 0 0 1 
Erysipeloid (N = 1) 0 1 0 0 0 
Mycetomatous (N = 1 1 0 0 0 0 
Basal cell carcinoma like (N = 1) 1 0 0 0 0 
Chancriform (N = 1) 1 0 0 0 0 
 
Figure 1
A  
(i)  (ii)  (iii)  
(ii)  
C  
(i)  
B  
D  
(i)  (ii)  
E  F  G  
(ii)  (i)  
H  I  J  K  
L  M  N    
O  
(i)  
(i)  (ii)  
(ii)  
LT  LM  LT  L  
LT  LT  LT  LT  
L  LT  LF  LT  
L  LT  NA  LT  
LT  LM  LM  LF  
LF  LM  
Figure 2
